Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.
Current Team (4)Update
Funding Rounds (4) - $55MUpdate
Board Members and Advisors (4)Update
IT and Healthcare VC
Montreux Equity Partners is a private investment firm dedicated to building the leading...
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and...
Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
198 Route 9 North
Manalapan, NJ 07726
- 06/30/14 -prnewswire.com